ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,868Medicare Part D Prescriptions Filled, Including Refills

Rank: 292 out of 6969

$850K Total Retail Price of All Prescriptions

Rank: 192 out of 6969

504 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 486 439 1 5
SIMVASTATIN 479 409 2 1
METOPROLOL SUCCINATE 403 388 3 22
AMLODIPINE BESYLATE 393 370 4 4
HYDROCODONE-ACETAMINOPHEN 386 250 S3 5 3
OMEPRAZOLE 244 202 6 6
ATORVASTATIN CALCIUM 240 239 7 11
BENAZEPRIL HCL 224 207 8 18
HYDROCHLOROTHIAZIDE 186 165 9 8
BENAZEPRIL-HYDROCHLOROTHIAZIDE 168 123 10 132
LOSARTAN-HYDROCHLOROTHIAZIDE 162 152 11 53
PRAVASTATIN SODIUM 157 147 12 19
ALLOPURINOL 155 137 13 35
SPIRIVA 147 104 14 66
SPIRONOLACTONE 146 118 15 102
PANTOPRAZOLE SODIUM 145 110 16 31
FUROSEMIDE 143 129 17 10
CARVEDILOL 130 122 18 25
CRESTOR 128 122 19 39
WARFARIN SODIUM 127 112 20 20
METFORMIN HCL 120 102 21 7
SERTRALINE HCL 115 86 22 38
TAMSULOSIN HCL 114 114 23 23
TRAMADOL HCL 106 96 24 27
DIOVAN 106 106 24 26
ADVAIR DISKUS 104 93 26 45
CITALOPRAM HBR 102 90 27 34
METOPROLOL TARTRATE 94 74 28 13
IRBESARTAN 93 93 29 392
ZOLPIDEM TARTRATE 93 64 29 16
LISINOPRIL 91 82 31 2
LOSARTAN POTASSIUM 90 80 32 12
BUPROPION HCL SR 90 62 32 195
BYSTOLIC 89 86 34 155
SPIRONOLACTONE-HCTZ 89 89 34 296
AMLODIPINE BESYLATE-BENAZEPRIL 87 85 36 91
VYTORIN 87 87 36 148
METFORMIN HCL ER 86 73 38 82
ALENDRONATE SODIUM 85 85 39 14
DONEPEZIL HCL 83 79 40 32
DIOVAN HCT 82 81 41 57
GABAPENTIN 79 45 42 17
BENICAR 78 66 43 107
CARISOPRODOL 77 21 R 44 69
FLUOXETINE HCL 71 66 45 43
RANITIDINE HCL 69 67 46 46
GLIMEPIRIDE 69 69 46 44
ISOSORBIDE MONONITRATE ER 68 67 48 81
NAMENDA 68 68 48 51
CLOPIDOGREL 67 62 50 48
ACTOS 66 66 51 61
PLAVIX 65 64 52 68
ZETIA 60 48 53 98
ESCITALOPRAM OXALATE 60 51 53 93
DIGOXIN 59 57 55 71
TOPIRAMATE 59 25 55 217
MORPHINE SULFATE ER 58 23 S2 57 90
AMITRIPTYLINE HCL 57 57 R 58 87
PREMARIN 56 56 R 59 156
MELOXICAM 56 41 59 36
AVODART 56 51 59 108
JANUVIA 55 55 62 41
ONGLYZA 53 53 63 164
CELEBREX 52 44 64 67
LOVASTATIN 52 52 64 15
POTASSIUM CHLORIDE 51 38 66 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.